Affiliation:
1. Gordon Center for Medical Imaging Department of Radiology Massachusetts General Hospital and Harvard Medical School Boston MA 02114 USA
2. Department of Biomedical Sciences and Department of Thoracic and Cardiovascular Surgery, Korea University Guro Hospital College of Medicine Korea University Seoul 08308 South Korea
Abstract
AbstractTwo of the most pressing challenges facing bioimaging are nonspecific uptake of intravenously administered contrast agents and incomplete elimination of unbound targeted agents from the body. Designing a targeted contrast agent that shows fast clearance from background tissues and eventually the body after complete targeting is key to the success of image‐guided interventions. Here, this work describes the development of renally clearable near‐infrared contrast agents and their potential use for dual‐channel image‐guided tumor targeting. cRGD‐ZW800‐PEG (800 nm channel) and ZW700‐PEG (700 nm channel) are able to visualize tumor margins and tumor vasculature simultaneously and respectively. These targeted agents show rapid elimination from the bloodstream, followed by renal clearance, which together significantly lower off‐target background signals and potential toxicity. To demonstrate its applicability, this multispectral imaging is performed in various tumor‐bearing animal models including lung cancer, pancreatic neuroendocrine tumors, breast, and ovarian cancer.
Funder
National Institutes of Health
National Institute of Biomedical Imaging and Bioengineering
Subject
Pharmaceutical Science,Biomedical Engineering,Biomaterials
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献